RemeOs Screw Receives Pass-Through Payment
Bioretec's RemeOs screw is the first and only osteopromotive absorbable metal implant for orthopedic use in the U.S. ...
Oct 01, 2025,
RemeOs Screw Receives Pass-Through Payment
9 Startups We Plan to Hear at MNVC
MNVC will feature dozens of orthopedic companies and provide attendees with a glimpse of the unmet needs that startups are...
Sep 29, 2025,
What We’re Watching in the Second Half of 2025
Five things we're watching as the orthopedic market's competitive landscape evolves and we move into the second half of 2025....
Sep 29, 2025,
Zimmer Biomet Gains PMDA Approval of Iodine-Treated Total Hip Replacement
The iTaperloc Complete and iG7 Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant...
Sep 26, 2025,
Spineart Raises Funding in Support of Global Growth
This new funding will fuel Spineart’s next phase of profitable growth, enabling the company to advance its innovation pipeline and...
Sep 26, 2025,
Poly Medicure to Acquire Citieffe
This strategic move provides Poly Medicure with an entry point into the large global orthopedics market, particularly in the trauma...
Sep 25, 2025,
SMAIO Signs Distribution Agreement with Highridge Medical
The partnership expands SMAIO’s business in the U.S. and drives adoption of its new open platform for customized implant solutions....
Sep 25, 2025,
Fracture Fixation in the News: A Quarterly Recap
Within 3Q25, these companies debuted products to help fix our fractures and deformities in shoulders, pelvis and toes throughout our...
Sep 25, 2025,
Keensight Capital Acquires Majority Stake in Isto Biologics
Founded in 2016, Isto Biologics is a regenerative medtech company developing and manufacturing orthobiologic products to help patients heal faster....
Sep 24, 2025,
IMPLANET Enters Distribution Agreement with TINAVI Medical
TiRobot is an autonomous cobot that is not fixed to the operating table, allowing for continuous adjustments throughout the procedure...
Sep 24, 2025,
Loading new posts...
No more posts
